31,014 Shares in Sabra Healthcare REIT, Inc. $SBRA Bought by Dockside LLC

Posted by Stanley Muller on Aug 15th, 2026

Dockside LLC bought a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) during the second quarter, HoldingsChannel.com reports. The firm bought 31,014 shares of the real estate investment trust’s stock, valued at approximately $605,000.

Several other large investors also recently bought and sold shares of SBRA. Rothschild Investment LLC increased its position in shares of Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the last quarter. Strengthening Families & Communities LLC purchased a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth about $29,000. Versant Capital Management Inc boosted its position in shares of Sabra Healthcare REIT by 70.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 603 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Up 0.8%

Shares of NASDAQ:SBRA opened at $20.32 on Friday. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The company has a market capitalization of $5.19 billion, a P/E ratio of 78.16, a P/E/G ratio of 1.55 and a beta of 0.64. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $22.77. The stock’s fifty day simple moving average is $20.00 and its 200-day simple moving average is $20.02.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The company had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. During the same quarter in the prior year, the business posted $0.38 EPS. The company’s revenue for the quarter was up 24.7% compared to the same quarter last year. As a group, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. Sabra Healthcare REIT’s payout ratio is 461.54%.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Robert W. Baird upped their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “neutral” rating in a report on Wednesday, July 22nd. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Scotiabank cut their price objective on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Seven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.25.

Read Our Latest Report on SBRA

About Sabra Healthcare REIT

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.